Orphanse Healthcare


Orphanse Healthcare is a company based in Lyon, France, specializing in the development of pharmaceutical products administered via transmucosal routes. Their main activity is R&D, focusing on developing alternative pharmaceutical solutions using their patented BPM® technology. They aim to create fast-acting, safe, simple, and patient-acceptable medications with positive economic impact, particularly targeting pediatric and dysphagic populations. The company also offers strategic and operational consulting services for biotech and pharmaceutical SMEs.

Industries

health-care
manufacturing
pharmaceutical

Nr. of Employees

small (1-50)

Orphanse Healthcare

Lyon, Rhone-Alpes, France, Europe


Products

ORH-01 (transmucosal product candidate)

Product candidate developed for transmucosal administration that completed a proof-of-concept study in 16 healthy volunteers; preparation for a pivotal study is ongoing.

Pre-formulation product programs (two projects)

Two additional transmucosal product development projects currently in pre-formulation stages.


Services

Strategic and operational consulting for biotech and pharmaceutical SMEs

Advisory and implementation services including development strategy, business development, project management, and support for preclinical activities (CMC and in vivo studies).

Expertise Areas

  • Transmucosal / buccal drug development
  • Formulation and pre-formulation
  • CMC development
  • Preclinical in vivo studies (pharmacology and toxicology)
  • Show More (5)

Key Technologies

  • Transmucosal / oromucosal delivery
  • Buccal drug delivery systems
  • Platform-based mucosal delivery
  • Formulation science and pre-formulation
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.